Skip to content

Neuroplasticity: all studies

Page 124 of 178: studies 1,231 to 1,240 of 1,773, newest first. Back to the neuroplasticity overview

Research

Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA

Frontiers in Neuroscience February 7, 2024 Jennifer Warner-Schmidt, Martin Stogniew, Blake Mandell et al. 6 citations

BackgroundPost-traumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. Available pharmacotherapies are limited, take weeks to show modest benefit and remain ineffective for up to 40% of patients. Methylone is currently in clinical development for the treatment of PTSD. Preclinical studies show rapid, robust and...

Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility

Molecular Psychiatry February 6, 2024 Merima Šabanović, Alberto Lazari, Marta Blanco-Pozo et al. 17 citations

Abstract Psychedelic drugs can aid fast and lasting remission from various neuropsychiatric disorders, though the underlying mechanisms remain unclear. Preclinical studies suggest serotonergic psychedelics enhance neuronal plasticity, but whether neuroplastic changes can also be seen at cognitive and behavioural levels is unexplored. Here we show that a single dose of the psychedelic...

DOI: 10.1038/s41380-024-02439-2 (opens in new tab) Full text (opens in new tab) Flexibility engineering Cognitive flexibility Cognition Cognitive psychology

Anti-inflammatory effects of ketamine in the treatment-resistant depression: a narrative review

Farmacja Polska February 3, 2024 Marta Jóźwiak-Bębenista, Paulina Sokołowska, Edward Kowalczyk et al.

Przedmiot badań. U części pacjentów z depresją szczególnie nie odpowiadających na leczenie standardowymi lekami przeciwdepresyjnymi lub z myślami bądź próbami samobójczymi, stan zapalny jako źródło cytokin, przyczynia się do braku odpowiedzi na zastosowane terapie. Szansą dla takich osób jest terapia przy pomocy ketaminy. S-ketamina to szybko działający lek przeciwdepresyjny o wysokiej...

Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice.

Pharmacology, Biochemistry, and Behavior February 1, 2024 Paul J Fletcher, Zhaoxia Li, Xiao Dong Ji et al. 2 citations

Psychedelic drugs, which share in common 5-HT2A receptor agonist activity, have shown promise in treating alcohol-use disorders (AUDs). Repeated exposure to ethanol (EtOH) induces molecular and behavioural changes reflective of neuroadaptations that may contribute to addiction. Psychedelic drugs can induce neuroplasticity also, raising the possibility that their potential clinical effects in...

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Ageing Research Reviews February 1, 2024 Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh et al. 29 citations

Psychedelics have traditionally been used for spiritual and recreational purposes, but recent developments in psychotherapy have highlighted their potential as therapeutic agents. These compounds, which act as potent 5-hydroxytryptamine (5HT) agonists, have been recognized for their ability to enhance neural plasticity through the activation of the serotoninergic and glutamatergic systems....

DOI: 10.1016/j.arr.2024.102211 (opens in new tab) 5-hydroxytryptamine receptors Alzheimer’s disease Brain-derived neurotrophic factor Dementia +7

Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial.

BMC Psychiatry January 26, 2024 Laetitia Vanderijst, Felix Hever, Anne Buot et al. 11 citations

A significant number of individuals with alcohol use disorder remain unresponsive to currently available treatments, which calls for the development of new alternatives. In parallel, psilocybin-assisted therapy for alcohol use disorder has recently yielded promising preliminary results. Building on extant findings, the proposed study is set to evaluate the feasibility and preliminary clinical...

DOI: 10.1186/s12888-024-05502-y (opens in new tab) Full text (opens in new tab) Psychedelic therapy Psilocybin-assisted therapy Serotonergic psychedelics Clinical trials +3

Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective

Entropy January 22, 2024 Giulio Ruffini, Edmundo Lopez-Sola, Jakub Vohryzek et al. 15 citations

We explore the intersection of neural dynamics and the effects of psychedelics in light of distinct timescales in a framework integrating concepts from dynamics, complexity, and plasticity. We call this framework neural geometrodynamics for its parallels with general relativity’s description of the interplay of spacetime and matter. The geometry of trajectories within the dynamical landscape of...

DOI: 10.3390/e26010090 (opens in new tab) Plasticity Statistical physics Artificial intelligence Cognitive science

Psychedelics for mental health: a biochemical perspective

The Biochemist January 19, 2024 Javier González-Maeso

Psychedelics, such as psilocybin, mescaline and lysergic acid diethylamide (LSD), are psychoactive substances that induce alterations in cognition, perception and sensory processing. Studies in rodent models and healthy human volunteers highlight the serotonin 5-HT2A receptor’s pivotal role in mediating hallucinogenic effects. More recent findings indicate that psychedelics induce lasting...

Ketamine Produces Antidepressant Effects by Inhibiting Histone Deacetylases and Upregulating Hippocampal Brain-Derived Neurotrophic Factor Levels in a Diisopropyl Fluorophosphate-Based Rat Model of Gulf War Illness.

Journal of Pharmacology and Experimental Therapeutics January 17, 2024 Ana Ribeiro-Davis, Dalia Y Al Saeedy, Fay M Jahr et al. 10 citations

Approximately one-third of Gulf War veterans suffer from Gulf War Illness (GWI), which encompasses mood disorders and depressive symptoms. Deployment-related exposure to organophosphate compounds has been associated with GWI development. Epigenetic modifications have been reported in GWI veterans. We previously showed that epigenetic histone dysregulations were associated with decreased...

DOI: 10.1124/jpet.123.001824 (opens in new tab) Full text (opens in new tab) Ketamine therapy Neuroscience research Veterans health Depression treatment +1

Esketamine Prevents Postoperative Emotional and Cognitive Dysfunction by Suppressing Microglial M1 Polarization and Regulating the BDNF-TrkB Pathway in Ageing Rats with Preoperative Sleep Disturbance

Molecular Neurobiology January 15, 2024 Yuxin Wen, Jiawen Xu, Jiahong Shen et al. 57 citations

Postoperative depression (POD) and postoperative cognitive dysfunction (POCD) have placed heavy burden on patients’ physical and mental health in recent years. Sleep disturbance before surgery is a common phenomenon that has been increasingly believed to affect patients’ recovery, especially in aged patients, while little attention has been paid to sleep disruption before surgery and the...